The Iliac/SFA/Popliteal Center

Filter Your Results

 

News

 

Treatment Strategies for Femoropopliteal Chronic Total Occlusions

Harry W. Donias, MD

April 2019—A chronic total occlusion (CTO) is present in nearly 50% of all patients undergoing endovascular treatment of infrainguinal peripheral arteries.1 The presence of a CTO has bee…

Enrollment Resumes in the TRANSCEND Trial of Surmodics' SurVeil Paclitaxel-Coated Balloon

April 17, 2019 -- Surmodics, Inc. announced that it has resumed patient enrollment for the TRANSCEND clinical trial and has completed approximately 75% of its goal of enrollin…

IMPERIAL Subanalyses Support Boston Scientific's Eluvia Stent in Calcified Lesions and CTOs

April 16, 2019 -- Boston Scientific Corporation announced that results from subanalyses of the IMPERIAL clinical trial for the company's Eluvia drug-eluting vascular stent…

FDA Approves Intact Vascular’s Tack Endovascular System

April 15, 2019 -- Intact Vascular, Inc. announced FDA approval for the 6-F Tack endovascular system, a dissection repair device implanted after percutaneous transluminal angio…

CIRSE Position Statement Addresses the Use of Paclitaxel-Coated Devices in PAD

April 12, 2019 -- The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) announced an updated CIRSE Position Statement on the use of paclitaxel-coated ba…

Nine-Month BOLSTER Data Published for BD's LifeStream Covered Stent in Iliac Artery

April 8, 2019 -- Nine-month findings from the BOLSTER study, which sought to assess the performance of the LifeStream balloon-expandable covered stent (BD Interventional) for …

BD Launches UltraScore 014 Focused Force PTA Balloon

April 1, 2019 -- BD (Becton, Dickinson and Company) announced the launch of its UltraScore 014 Focused Force percutaneous transluminal angioplasty (PTA) balloon. The device is…

Cook Medical Letter to Physicians Addresses Paclitaxel Data

March 26, 2019 -- In a letter to physicians, Cook Medical communicated the company's latest information and insights regarding concerns about long-term safety of paclitaxe…

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.